2024-07-01 2025-06-30 false No description of principal activity Capium Accounts Production 1.1 14197235 2024-07-01 2025-06-30 14197235 bus:FullAccounts 2024-07-01 2025-06-30 14197235 bus:Micro-entities 2024-07-01 2025-06-30 14197235 bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 14197235 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 14197235 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 14197235 2024-07-01 2025-06-30 14197235 2025-06-30 14197235 bus:RegisteredOffice 2024-07-01 2025-06-30 14197235 core:WithinOneYear 2025-06-30 14197235 core:AfterOneYear 2025-06-30 14197235 1 2024-07-01 2025-06-30 14197235 bus:Director1 2024-07-01 2025-06-30 14197235 bus:Director1 2025-06-30 14197235 bus:Director1 2023-07-01 2024-06-30 14197235 bus:Director2 2024-07-01 2025-06-30 14197235 bus:Director2 2025-06-30 14197235 bus:Director2 2023-07-01 2024-06-30 14197235 2023-07-01 14197235 bus:LeadAgentIfApplicable 2024-07-01 2025-06-30 14197235 2023-07-01 2024-06-30 14197235 2024-06-30 14197235 core:WithinOneYear 2024-06-30 14197235 core:AfterOneYear 2024-06-30 14197235 bus:EntityAccountantsOrAuditors 2023-07-01 2024-06-30 14197235 core:PlantMachinery 2024-07-01 2025-06-30 14197235 core:PlantMachinery 2025-06-30 14197235 core:PlantMachinery 2024-06-30 14197235 core:ComputerEquipment 2024-07-01 2025-06-30 14197235 core:ComputerEquipment 2025-06-30 14197235 core:ComputerEquipment 2024-06-30 14197235 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-06-30 14197235 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-06-30 14197235 core:CostValuation core:Non-currentFinancialInstruments 2025-06-30 14197235 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 14197235 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-06-30 14197235 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 14197235 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-06-30 14197235 core:Non-currentFinancialInstruments 2025-06-30 14197235 core:Non-currentFinancialInstruments 2024-06-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14197235
England and Wales
NAZAMI MEDICAL LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 July 2024 End date: 30 June 2025

NAZAMI MEDICAL LIMITED Contents Page For the year ended 30 June 2025
Company information | 1
Statement of financial position | 2

NAZAMI MEDICAL LIMITED Company Information For the year ended 30 June 2025
Directors | Muhammad Jareer Ahsen Noureen Liaqat
Registered Number | 14197235
Registered Office | 7A LADY ROYD GARDENS BRADFORD ENGLAND BD9 6RF
1

NAZAMI MEDICAL LIMITED Statement of Financial Position As at 30 June 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 409 |  |  | 517
Current assets |  | 214,293 |  |  | 134,058 |
Creditors: amount falling due within one year |  | (51,118) |  |  | (33,159) |
Net current assets |  |  | 163,175 |  |  | 100,899
Total assets less current liabilities |  |  | 163,584 |  |  | 101,416
Net assets |  |  | 163,584 |  |  | 101,416
Capital and reserves |  |  | 163,584 |  |  | 101,416
NOTES TO THE ACCOUNTS General Information NAZAMI MEDICAL LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14197235, registration address 7A LADY ROYD GARDENS, BRADFORD ENGLAND, BD9 6RF. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company.
2. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
For the year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the board of directors on 19 March 2026 and were signed on its behalf by:
-------------------------------- Muhammad Jareer Ahsen Director
2